Scientists have successfully used an inhibitor of the chemical 20-HETE to control the growth and spread of human glioblastomas and breast cancer in laboratory models
In the future, scientists want to further investigate the molecules and examine their capacity as predictive biomarkers of taxane-based radiochemotherapy